Citation Impact
Citing Papers
Diagnosis and management of acute myeloid leukemia in adults: recommendations from an international expert panel, on behalf of the European LeukemiaNet
2009 Standout
5 Treatment and prognostic factors in acute myeloid leukaemia
1996
Prognostic factors for response and survival after high-dose cyclophosphamide, carmustine, and etoposide with autologous bone marrow transplantation for relapsed Hodgkin's disease.
1989
Etoposide: four decades of development of a topoisomerase II inhibitor
1998 Standout
A phase III trial comparing idarubicin and daunorubicin in combination with cytarabine in acute myelogenous leukemia: a Southeastern Cancer Study Group Study.
1992
Perspectives on cancer therapy-induced mucosal injury
2004 Standout
Prospective randomised trial of amifostine cytoprotection in myeloma patients undergoing high-dose melphalan conditioned autologous stem cell transplantation
2005
Randomised comparison of addition of autologous bone-marrow transplantation to intensive chemotherapy for acute myeloid leukaemia in first remission: results of MRC AML 10 trial
1998
Amifostine
2001
Salivary hypofunction: An update on aetiology, diagnosis and therapeutics
2014
PLGA-based nanoparticles: An overview of biomedical applications
2012 Standout
Amifostine in clinical oncology: current use and future applications
2002
Dose Intensification of Etoposide in the BEAM ABMT Protocol for Malignant Lymphoma
1995
Anthrazykline in der Krebstherapie
1997 Standout
Autologous Bone Marrow Transplantation as Compared with Salvage Chemotherapy in Relapses of Chemotherapy-Sensitive Non-Hodgkin's Lymphoma
1995 Standout
Animal models of autoimmunity and their relevance to human diseases
2000 StandoutNobel
Biological roles of glycans
2016 Standout
Autologous bone marrow transplantation in children
1988
Chemotherapy-Induced Anemia in Adults: Incidence and Treatment
1999
Epidemiology and Outcome of Zygomycosis: A Review of 929 Reported Cases
2005 Standout
Graft-versus-host disease
2009 Standout
The pathobiology of mucositis
2004 Standout
Circos: An information aesthetic for comparative genomics
2009 Standout
Hematopoietic Stem-Cell Transplantation
2006 Standout
Bone Marrow Transplantation
1994
A review of autologous hematopoietic cell transplantation
2000 Nobel
Idarubicin
1991
Cyclophosphamide decreases O6-alkylguanine-DNA alkyltransferase activity in peripheral lymphocytes of patients undergoing bone marrow transplantation
1992
Autologous Bone Marrow Transplantation
1989
Anemia of Chronic Disease
2005 Standout
Symptoms and Suffering at the End of Life in Children with Cancer
2000 Standout
Revised Recommendations of the International Working Group for Diagnosis, Standardization of Response Criteria, Treatment Outcomes, and Reporting Standards for Therapeutic Trials in Acute Myeloid Leukemia
2003 Standout
Bone Marrow Transplantation
1993
Clinacanthus nutansExtracts Are Antioxidant with Antiproliferative Effect on Cultured Human Cancer Cell Lines
2013 Standout
Autologous hematopoietic stem cell transplantation in intermediate and high grade Non-Hodgkin's lymphoma: A review
1993
Anthracyclines suppress pheochromocytoma cell characteristics, including metastasis, through inhibition of the hypoxia signaling pathway
2017 StandoutNobel
Bone marrow and peripheral blood stem cell transplantation for malignancy.
1998
Anthracycline analogs The past, present, and future
1986
Patient characteristics associated with successful mobilizing and autografting of peripheral blood progenitor cells in malignant lymphoma
1994
Modulation of cyclophosphamide activity by O ? 6 -alkylguanine-DNA alkyltransferase
1999 StandoutNobel
How important are comprehensive literature searches and the assessment of trial quality in systematic reviews? Empirical study
2003 Standout
The Absolute Number of Peripheral Blood CD34+ Cells Predicts a Timing for Apheresis and Progenitor Cell Yield in Patients with Hematologic Malignancies and Solid Tumors
2003 StandoutNobel
Predictors of therapy-related leukemia and myelodysplasia following autologous transplantation for lymphoma: an assessment of risk factors
2000
Autologous Stem Cell Transplantation in Acute Myelocytic Leukemia
1998
The pharmaceutics and delivery of therapeutic polypeptides and proteins
1993
Bone Marrow Transplant
1990 Standout
Prognostic significance of activating FLT3 mutations in younger adults (16 to 60 years) with acute myeloid leukemia and normal cytogenetics: a study of the AML Study Group Ulm
2002
Risk-assessment in diffuse large cell lymphoma at first relapse. A study by the Italian Intergroup for Lymphomas.
2001
Specificity of Effector T Lymphocytes in Autologous Graft-Versus-Host Disease: Role of the Major Histocompatibility Complex Class II Invariant Chain Peptide
1997
Allogeneic, syngeneic, and autologous marrow transplantation for Hodgkin's disease: the 21-year Seattle experience.
1993
The Importance of Diagnostic Cytogenetics on Outcome in AML: Analysis of 1,612 Patients Entered Into the MRC AML 10 Trial
1998 Standout
Acute toxicity and first clinical results of intensive postinduction therapy using a modified busulfan and cyclophosphamide regimen with autologous bone marrow rescue in first remission of acute myeloid leukemia [see comments]
1989
Results of a randomized trial comparing idarubicin and cytosine arabinoside with daunorubicin and cytosine arabinoside in adult patients with newly diagnosed acute myelogenous leukemia
1991
Hodgkin's lymphoma
2003
Anthraquinones As Pharmacological Tools and Drugs
2016 Standout
Works of A Congiu being referenced
High-dose chemotherapy with autologous bone marrow transplantation in 50 advanced resistant Hodgkin's disease patients: an Italian study group report.
1988
MACOP-B versus ProMACE-MOPP in the treatment of advanced diffuse non-Hodgkin's lymphoma: results of a prospective randomized trial by the non-Hodgkin's Lymphoma Cooperative Study Group.
1994
Cyclosporine-induced graft-versus-host disease after autologous bone marrow transplantation in hematological malignancies
1991
Autologous Unpurged Bone Marrow Transplantation for Acute Non Lymphoblastic Leukemia in First Remission
1991
Idarubicin in combination with etoposide and cytarabine in adult untreated acute non lymphoblastic leukemia
1987
Nine years' experience with ABMT in 128 patients with Hodgkin's disease: an Italian study group report.
1991
Autologous bone marrow transplantation as adjuvant treatment for high-risk Hodgkin's disease in first complete remission after MOPP/ABVD protocol.
1991
Massive chemotherapy with non-frozen autologous bone marrow transplantation in 13 cases of refractory Hodgkin's disease
1985
Autologous bone marrow transplantation for adult advanced stage lymphoblastic lymphoma in first CR. A study of the NHLCSG.
1991
Amifostine (WR-2721), a cytoprotective agent during high-dose cyclophosphamide treatment of non-Hodgkin's lymphomas: a phase II study
2000
Autologous unpurged bone marrow transplantation for acute non-lymphoblastic leukaemia in first complete remission.
1988
4-Demethoxydaunorubicin (Idarubicin) in refractory or relapsed acute leukemias. A pilot study
1985